TEL AVIV, Israel, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Today, Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced that it has entered into an agreement with JKI, established by the fund managed and operated by J-Will, whereby all shares of Teva Takeda Pharma Limited and its wholly owned subsidiary Teva Takeda Yakuhin Ltd. will…
Sun, 23 Feb 2025 16:00:00 GMT TEL AVIV, Israel, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will conduct a conference call and live webcast at 8 am E.T ...
Sun, 09 Feb 2025 22:16:00 GMT Axsome Therapeutics (AXSM) announced that it has entered into a settlement agreement ... financial news. Try Now>> See Insiders’ Hot Stocks on TipRanks >> Read More on AXSM: Teva Pharmaceutical ...
Sun, 09 Feb 2025 22:00:00 GMT Axsome Therapeutics, Inc. (NASDAQ: AXSM) (Axsome), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it has entered into a ...
Sun, 09 Feb 2025 20:00:00 GMT Under the terms of the settlement agreement, Axsome will grant Teva a license to sell its generic version of AUVELITY beginning on or after March 31, 2039, if pediatric exclusivity is granted for ...
Sun, 12 Jan 2025 22:44:00 GMT Klinge Biopharma GmbH (Klinge) holds the exclusive global commercialization rights for FYB203, Formycon's biosimilar candidate to Eylea®1 Agreement builds on the proven and successful collaboration of ...
